Could new reconstruction CT techniques challenge MRI for the detection of brain metastases in the context of initial lung cancer staging?

Millon, Domitille;Byl, David;Collard, Philippe;Cambier, Samantha;Coche, Emmanuel;et.al.
(2018) European Radiology : journal of the European Congress of Radiology — Vol. 28, n° 2, p. 770-779 (2018)

Files

Millon2018_Article_CouldNewReconstructionCTTechni.pdf
  • Open Access
  • Adobe PDF
  • 8.52 MB

Details

Authors
  • Millon, Domitilleorcid-logoUCLouvain
    Author
  • Byl, DavidUCLouvain
    Author
  • Collard, PhilippeUCLouvain
    Author
  • Cambier, SamanthaUCLouvain
    Author
  • Van Maanen, AlineUCLouvain
    Author
  • Author
Show more
Abstract
(en) OBJECTIVES: To evaluate the diagnostic performance of brain CT images reconstructed with a model-based iterative algorithm performed at usual and reduced dose. METHODS: 115 patients with histologically proven lung cancer were prospectively included over 15 months. Patients underwent two CT acquisitions at the initial staging, performed on a 256-slice MDCT, at standard (CTDIvol: 41.4 mGy) and half dose (CTDIvol: 20.7 mGy). Both image datasets were reconstructed with filtered back projection (FBP) and iterative model-based reconstruction (IMR) algorithms. Brain MRI was considered as the reference. Two blinded independent readers analysed the images. RESULTS: Ninety-three patients underwent all examinations. At the standard dose, eight patients presented 17 and 15 lesions on IMR and FBP CT images, respectively. At half-dose, seven patients presented 15 and 13 lesions on IMR and FBP CT images, respectively. The test could not highlight any significant difference between the standard dose IMR and the half-dose FBP techniques (p-value = 0.12). MRI showed 46 metastases on 11 patients. Specificity, negative and positive predictive values were calculated (98.9-100 %, 93.6-94.6 %, 75-100 %, respectively, for all CT techniques). CONCLUSION: No significant difference could be demonstrated between the two CT reconstruction techniques. KEY POINTS: • No significant difference between IMR100 and FBP50 was shown. • Compared to FBP, IMR increased the image quality without diagnostic impairment. • A 50 % dose reduction combined with IMR reconstructions could be achieved. • Brain MRI remains the best tool in lung cancer staging.
Affiliations

Citations

Millon, D., Byl, D., Collard, P., Cambier, S., Van Maanen, A., Vlassenbroek, A., & Coche, E. (2018). Could new reconstruction CT techniques challenge MRI for the detection of brain metastases in the context of initial lung cancer staging? European Radiology : journal of the European Congress of Radiology, 28(2), 770-779. https://doi.org/10.1007/s00330-017-5021-7 (Original work published 2018)